Technology | 2021.12.17
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
FRANKLIN LAKES, N.J., Dec. 17, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput molecular testing for infectious diseases....
For more information, please visit
http://prnmedia.prnewswire.com/news-rele[...]m-for-core-labs-301447232.html
